We are live on
!
Find out more
BC
Blackcrane Capital Portfolio holdings
AUM
$16.3M
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+8.57%
1 Year Est. Return
-19.53%
3 Year Est. Return
+40.04%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.9M
AUM Growth
+$8.07M
(+19%)
Cap. Flow
+$6.66M
Cap. Flow
% of AUM
13.08%
Top 10 Holdings %
Top 10 Hldgs %
98.74%
Holding
11
New
3
Increased
4
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Open Text
OTEX
|
+$6.49M |
| 2 |
PROF
Profound Medical
PROF
|
+$2.66M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$1.36M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$1.11M |
| 5 |
WIX.com
WIX
|
+$198K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avita Medical
RCEL
|
+$3.65M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$1.57M |
| 3 |
Microsoft
MSFT
|
+$290K |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$2.39K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.2% |
| 2 | Healthcare | 48.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
WIX.com
WIX
$2.15B
| $10.6M | 20.79% |
42,363
+753
| +2% | +$198K |
|
2
Nice
NICE
$5.87B
| $7.58M | 14.87% |
26,721
+769
| +3% | +$187K |
|
|
PROF
3
Profound Medical
PROF
$249M
| $7.03M | 13.8% |
341,767
+144,843
| +74% | +$2.66M |
|
|
4
Open Text
OTEX
$5.65B
| $6.9M | 13.55% |
+151,800
| New | +$6.49M |
|
|
AXNX
5
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.23M | 12.23% |
124,736
-51
| -0% | -$2.39K |
|
|
6
Avita Medical
RCEL
$157M
| $5.73M | 11.25% |
308,504
-166,478
| -35% | -$3.65M |
|
|
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.2M | 4.32% |
25,641
-18,471
| -42% | -$1.57M |
|
|
MYOV
8
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.93M | 3.78% |
+69,695
| New | +$1.36M |
|
|
9
Neurocrine Biosciences
NBIX
$17.2B
| $1.1M | 2.16% |
+11,499
| New | +$1.11M |
|
|
10
Microsoft
MSFT
$2.93T
| $1.01M | 1.99% |
4,555
-1,349
| -23% | -$290K |
|
11
Takeda Pharmaceutical
TAK
$54.8B
| $641K | 1.26% |
35,236
+9,513
| +37% | +$167K |
|
Similar funds
FQ
AG
SCM
CFG
YEPV
WIA
LSM
FFIM
Blackcrane Capital's Q4 2020 Portfolio in Review
As of Q4 2020, Blackcrane Capital held 11 positions worth $50.9M, up 19% from $42.9M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Blackcrane Capital deployed $6.66M of net new capital in Q4 2020, opening 3 new positions and adding to 4 existing holdings. Its largest new stake was Open Text: 151,800 shares worth $6.9M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 41% a quarter earlier, followed by Healthcare.
On the sell side, the largest reduction was Avita Medical, an estimated $3.65M trimmed.
- Blackcrane Capital's largest Q4 2020 buy was Open Text: 151,800 shares worth $6.9M.
- Blackcrane Capital added most to Profound Medical in Q4 2020, an estimated $2.66M increase.
- Blackcrane Capital's biggest Q4 2020 reduction was Avita Medical, cutting an estimated $3.65M.
- Blackcrane Capital's ten largest holdings make up 99% of its $50.9M portfolio in Q4 2020.
- Blackcrane Capital opened 3 new positions and closed 0 in Q4 2020.
- Blackcrane Capital's portfolio value rose 19% quarter-over-quarter to $50.9M.
Based on Blackcrane Capital's 13F filing for Q4 2020, filed 10 Feb 2021.